MHC-I upregulation by macbecin II in the solid tumors potentiates the effect of active immunotherapy
Abstract We aimed to restore MHC-I expression on the surface of solid tumors including breast cancer and melanoma cells to regain sensitivity to immunotherapy and suppress metastatic progression. We screened a natural compound library and identified macbecin II as a reagent that upregulates MHC-I ex...
Saved in:
| Main Authors: | Ravindra Pramod Deshpande, Kerui Wu, Shih-Ying Wu, Abhishek Tyagi, Eleanor C Smith, Jee-Won Kim, Kounosuke Watabe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2025-03-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s44321-025-00213-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of TUBB3 as an immunotherapy target in lung cancer by genome wide in vivo CRISPR screening
by: Dan Zhao, et al.
Published: (2025-02-01) -
MHC-I pathway disruption by viruses: insights into immune evasion and vaccine design for animals
by: Yanan Wu, et al.
Published: (2025-05-01) -
Ghrelin-induced neuronal NPY promotes brain metastasis in lung cancer patients with low BMI
by: Abhishek Tyagi, et al.
Published: (2025-07-01) -
Inhibitory effect of Endostar on HIF-1 with upregulation of MHC-I in lung cancer cells
by: Ming-Zhen Zhao, et al.
Published: (2025-12-01) -
OnmiMHC: a machine learning solution for UCEC tumor vaccine development through enhanced peptide-MHC binding prediction
by: Fangfang Jian, et al.
Published: (2025-02-01)